RxDoctor Payments Data

Dylan Payne, DO

Psychiatry · Pittsburgh, PANPI 1194985218

Payments from drug & device makers

$1,229in general payments, 2019–2025

Across 57 payments — averaging $21.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$380
  • Teva Pharmaceuticals USA, Inc.$256
  • Johnson & Johnson$216
  • Otsuka America Pharmaceutical, Inc.$134
  • Alkermes, Inc.$69
  • Lundbeck LLC$51
  • plus $122 from 6 others

What the payments were for

  • Food & beverage$1,11791%
  • Education$1119%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,229 in reported general payments places this provider in the 75th percentile of 1,838 psychiatry providers in Pennsylvania.

See all psychiatry providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$14,686
Medicare patients
48
Services billed
188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole12$18,254
TrintellixVortioxetine Hydrobromide17$11,270
Duloxetine Hcl107$2,129
Doxepin Hcl48$1,740
Aripiprazole47$1,557
Desipramine Hcl12$1,256
Ziprasidone Hcl33$1,185
Trazodone Hcl67$1,181
Hydroxyzine Hcl78$1,022
Bupropion XlBupropion Hcl67$974
Lorazepam96$720
Prazosin Hcl22$526
Clozapine29$502
Quetiapine Fumarate65$429
Lamotrigine43$423

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$134$18,25412 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$14$11,27017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,838 psychiatry providers in Pennsylvania.

Other psychiatry in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →